It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Thoughtful1
feds pay but haven't
originally posted by: texasgirl
hope it's the right oneedit on 1/2/2022 by CrazyFox because: Oop
In this totalitarian materialistic environment, Carl Gustav Jung had the courage to propose that our mind is guided by a system of forms, the archetypes, which are powerful, even though they don’t carry any mass or energy, and which are real, even though they are invisible. The archetypes exist, as Jung ([3], pp. 43v44) described, in a “psychic system of a collective, universal, and impersonal nature”. Out of this system, the invisible forms can appear in our mind and guide “our imagination, perception, and thinking”.
In this essay, we will describe the similarities between Carl Gustav Jung’s psychology and Quantum ontology. Our description will show that Jung’s teaching is more than psychology: it is a form of spirituality. By “spirituality”, we mean a view of the world that accepts the numinous at the foundation of the cosmic order. In the same way, Quantum Physics is more than physics: it is a new form of mysticism, which suggests the interconnectedness of all things and beings and the connection of our minds with a cosmic mind.
In “Infinite Potential” [23] this phenomenon has been described in the following way: At the foundation of the visible world we find Entities, which always appear to us as Elementary Things, when we interact with them. However, when they are on their own, they become waves. As waves, they have lost all mass, and they have become pure forms, patterns of information, something mindlike or thoughtlike. Accordingly, we can call the units of existence at the foundation of the world “ETs”, meaning Elementary Things, of Elementary Thoughts; or, simply, EntiTies.
NIH
originally posted by: duncanhidao
Dr. Stefano Manera ✨
WHAT DO DOCTORS USED TO OBSERVE IN THESE LAST MONTHS ?
- Awakenings of herpes forms that have been dormant for years, or even worse, Epstein Barr, a potential vector / facilitator / trigger of very serious pathologies, including neoplastic ones;
- frequent Guillain-Barré syndromes (inflammatory neuropathy that from an initial state of weakness leads to paresis of the lower and upper limbs);
- facial hemiparesis;
- confusional states with phenomena of 'hallucinations';
- increase in psychiatric symptoms (anxiety, depression, insomnia, panic attacks, suicidal intentions);
- onset of fibromyalgia-like syndromes;
- increase in neuropathies;
- metrorrhagia;
- changes in the menstrual cycle;
- myocarditis from one case per 100 thousand adults to a frequent phenomenon among young and very young people;
- dramatic increase in sports deaths;
- tumor relapses even in subjects who have been in remission of the disease for a long time;
- sudden lymph node proliferation '.
Anyone talk about it?
Between 1992 and 2008, De Groot also contributed to the Yale HIV in Prison program and Massachusetts Correctional Institution at Framingham, providing medical treatment to inmates, founded the GAIA Vaccine Foundation for improving global AIDS treatment, and founded a free clinic in Rhode Island, Clinica Esperanza. Her current work at the Clinica Esperanza includes the nurse-run CHEER Clinic, a walk in clinic pilot program that serves as an alternative to non-urgent ER visits.
The concept behind these descriptors is that a minimal set of antigens that induces a competent immune response to a pathogen or neoplasm can be discovered using immunoinformatics, and that administration of these epitopes in the right delivery vehicle and with the correct adjuvant will result in a degree of protection against infection by the pathogen. In short, the T cell-driven approach to developing vaccines is based on these fundamental principles: Payload + Adjuvant + Delivery vehicle = Vaccine.
Members of the FastVax consortium are well aware that there are many obstacles to overcome before the proposed “rapid response” or FastVax platform for biodefense vaccines can be implemented. Nonetheless, there is a critical national need for an accelerated vaccine design, development and production process that can be accomplished in weeks, not months, in the event of a serious infectious disease outbreak or biowarfare attack.
Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?
SEARCHING FOR A CURE: Anne De Groot founded EpiVax in 1998 with her research partner Bill Martin. The company has developed vaccines for HIV, tuberculosis, smallpox and other diseases.
She called the technology EpiMatrix. In 1998, she and her research partner Bill Martin founded EpiVax Inc. and licensed the algorithms, using them in-house to develop vaccines for HIV, tuberculosis, smallpox and others, and making them available to industry clients.